neurogenic rosacea

Recent Rosacea Blog Posts

Pregabalin (Lyrica) for Neurogenic Rosacea

The correspondence section in December’s edition of Clinical and Experimental Dermatology has a brief note from 3 doctors from the UK who describe a 61 year old sufferer of neurogenic rosacea. This patient was successfully treated with Pregabalin (Lyrica). Pregabalin is listed as one of the possible treatments for neurogenic rosacea. The authors suggest that […]

Continue Reading

Now that the collection of symptoms called Neurogenic Rosacea has become more widely known, new discussions can take place as, for example how to best treat it. This recently published abstract details a patient who suffered debilitating facial redness and burning. The patient was treated with the invasive and possibly irreversible procedure Endoscopic Thoracic Sympathectomy. The patient […]

Continue Reading

NRS highlights Neurologic form of Rosacea

The NRS Blog today mentions the recent publications that raise a possible new Subset of Rosacea. Even though this is just a passing reference, it is good to see that the NRS is willing to openly consider changes to the Standard Rosacea Classification. As the NRS was responsible for the assembling the expert committee that […]

Continue Reading

The recently published paper that called for the creation of Neurogenic Rosacea subtype contained an interesting disclosure. We are told that one of the paper’s authors, Professor Martin Steinhoff MD PhD , holds a related patent and research grant from Galderma. Related Rosacea Grant Dr. Steinhoff, along with Dr. Feramisco, received a $25,000 grant in […]

Continue Reading

This article is the third in a series featuring Neurogenic Rosacea. The first two articles are here: Neurogenic Rosacea: a new subtype for those with dysfunctional facial nerves and What is Neurogenic Rosacea? Recently a group of doctors from Stanford became the first to publish a call for a new subtype of rosacea, called Neurogenic […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.